SCHEMBL4297377

SCHEMBL4297377

CN[C@@H](CS)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9954953 1.00
SCHEMBL10172376 1.00
Hydrochloric Acid SCHEMBL11129917 0.98
SCHEMBL13227961 0.82
SCHEMBL2614011 0.82
SCHEMBL13233684 0.82
SCHEMBL8976122 0.81
SCHEMBL10786570 0.81
Urea SCHEMBL22721245 0.81 KDM4E (0.54)
Acetamide SCHEMBL27901069 0.79 ALOX15 (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166114-B Cyclic tetramer compounds as inhibitors of proprotein convertase subtilisin/KEXIN type 9 (PCSK 9) for the treatment of metabolic disorders 诺华股份有限公司 2025-01-03 CN disclosed
WO-2022271536-A1 SYNTHESIS OF COVALENT PROTEIN DIMERS THAT CAN INHIBIT MYC-DRIVEN TRANSCRIPTION MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2022-12-29 WO disclosed
US-20200407409-A1 EGF(A) ANALOGUES WITH FATTY ACID SUBSTITUENTS CHEN JIANHE (CN) 2020-12-31 US disclosed
US-20200165313-A1 EGF(A) ANALOGUES, PREPARATION, FORMULATIONS AND USES THEREOF NOVO NORDISK A/S (DK) 2020-05-28 US disclosed
EP-2768971-A1 METHODS FOR THE DETECTION AND THE TREATMENT OF CARDIAC REMODELING Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2014-08-27 EP disclosed
WO-2013057313-A1 METHODS FOR THE DETECTION AND THE TREATMENT OF CARDIAC REMODELING INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2013-04-25 WO disclosed
WO-2009156462-A2 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2009-12-30 WO disclosed
EP-0488144-A1 Benzodioxole derivatives and hepatopathy improvers comprising the same TSUMURA & CO. (JP) 1992-06-03 EP disclosed
EP-0051682-B1 CYSTEINE DERIVATIVES AND PROCESS FOR THEIR PREPARATION MITSUBISHI KASEI CORPORATION (JP) 1984-09-05 EP disclosed
US-4440788-A REGENERATION OF LIVER CELLS MITSUBISHI CHEMICAL INDUSTRIES, LIMITED (JP) 1984-04-03 US disclosed
EP-0051682-A1 CYSTEINE DERIVATIVES AND PROCESS FOR THEIR PREPARATION MITSUBISHI KASEI CORPORATION (JP) 1982-05-19 EP disclosed